Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | AEM | XOM |
|---|---|---|
| Price | $192.81 | $161.49 |
| Change today | ▼ 1.41% | ▲ 0.16% |
| Market cap | $97.63B | $664.03B |
| Return, 3 months | +25.9% | +18.7% |
| Return, year to date | +14.8% | +36.9% |
| Return, 1 year | +23.7% | +45.1% |
| P/E (TTM) | 16.5 | 20.8 |
| P/B | 3.4 | 2.6 |
| P/E percentile vs own 5y | 40th | 90th |
| Dividend yield | 0.88% | 2.53% |
| Revenue growth (YoY, latest qtr) | +35.0% | +44.1% |
| Net profit growth (YoY) | +49.8% | +102.4% |
| Gross margin | 62.9% | 20.6% |
| Operating margin | 58.5% | 10.7% |
| Net margin | 40.4% | 9.1% |
| Return on equity | 23.0% | 12.6% |
| Analyst target vs. price | +15.5% | +5.4% |
| Analyst buy share | 70% | 50% |
| RSI (14) | 50 | 51 |
| 30-day volatility | 50.8% | 25.7% |
| Max drawdown, 1 year | -45.7% | -20.1% |
| Trend read | Leaning bearish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.